Improved transfection of HUVEC and MEF cells using DNA complexes with magnetic nanoparticles in an oscillating field

Journal of Genetics

Volumn 91, Issue 2, 2012, Pages 223-227

  Lim, Jenson ^a   Dobson, Jon ^b,c  

^a KEELE UNIVERSITY   (United Kingdom)

^b University of Florida   (United States)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

human umbilical vein endothelial cells; magnetic nanoparticles; magnetofection; mouse embryonic fibroblasts; oscillating magnet array; transfection

Indexed keywords

FERRIC ION; FERRIC OXIDE; GREEN FLUORESCENT PROTEIN; NANOPARTICLE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL SHAPE; CULTURE MEDIUM; CULTURE TECHNIQUE; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; HUMAN; MAGNETIC FIELD; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; PLASMID; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SHAPE; CULTURE MEDIA, SERUM-FREE; FERRIC COMPOUNDS; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC FIELDS; MICE; NANOPARTICLES; PLASMIDS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 84866106725     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-012-0164-4     Document Type: Article

References (14)

1. Dobson J. 2006 Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 13, 283-287.
2. Dobson J. 2008 Remote control of cellular behaviour with magnetic nanoparticles. Nat. Nanotechnol. 3, 139-143.
3. Fouriki A., Farrow N., Clements M. A. and Dobson J. 2010 Evaluation of the magnetic field requirements for magnetic nanoparticle-based gene transfection. NanoReviews1, 5167.
4. Jenkins S. I., Pickard M. R., Granger N. and Chari D. M. 2011 Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies. ACS Nano. 5, 6527-6538.
5. Kamau S. W., Hassa P. O., Steitz B., Petri-Fink A., Hofmann H., Hofmann-Amtenbrink H. et al. 2006 Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res. 34, e40.
6. Krötz F., Sohn H. Y., Glow T., Plank C. and Pohl U. 2003 Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vasc. Res. 40, 425-434.
7. Lee C. H., Kim J. H., Lee H. J., Jeon K., Lim H., Choi H. et al. 2011 The generation of iPS cells using non-viral magnetic nanoparticle based transfection. Biomaterials32, 6683-6691.
8. Liu Z., Zheng M., Meng F. and Zhong Z. 2011 Non-viral gene transfection in vitro using endosomal pH-sensitive reversibly hydrophobilized polyethylenimine. Biomaterials32, 9109-9119.
9. McBain S. C., Griesenbach U., Xenariou S., Keramane A., Batich C. D., Alton E. W. et al. 2008 Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology19, 405102.
10. Muthana M., Scott S. D., Farrow N., Morrow F., Murdoch C., Grubb S. et al. 2008 A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 15, 902-910.
11. Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A. et al. 2006 Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension48, 165-171.
12. Pickard M., and Chari D. 2010 Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine (Lond)5, 217-232.
13. Plank C., Schillinger U., Scherer F., Bergemann C., Rémy J. S., Krötz F. et al. 2003 The magnetofection method: using magnetic force to enhance gene delivery. Biol. Chem. 384, 737-747.
14. Seki T., Irie N., Nakamura K., Sakaue H., Ogawa W., Kasuga M. et al. 2006 Fused protein of deltaPKC activation loop and PDK1-interacting fragment (deltaAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells. Genes Cells11, 1051-1070.